Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Abbott Laboratories patentsThe following is a sampling of recent Abbott Laboratories patent applications (USPTO Patent Application #, Patent Title) sorted by month.
August 2012 - Abbott Laboratories patents
20120219562 - Methods of treating psoriasis by administration of antibodies to the p40 subunit of il-12 and/or il-23
20120219943 - Methods of prognosis and diagnosis in chronic heart failure
20120220572 - Tricyclic inhibitors of kinases
20120213733 - Anti-infective agents and uses thereof
20120214848 - [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
20120209368 - System and method for delivering a stent to a bifurcated vessel
20120201746 - Half immunoglobulin binding proteins and uses thereof
20120201781 - Treatment of osteoarthritis and pain
20120202217 - Autoantibody enhanced immunoassays and kits
20120202295 - Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
20120202844 - Crystal forms of kinase inhibitors
20120202858 - Solid pharmaceutical dosage form
20120203002 - Crystalline forms of kinase inhibitors
20120195885 - Compositions containing glycosylated antibodies and uses thereof
20120195900 - Tri-variable domain binding proteins and uses thereof
20120196792 - Macrocyclic hepatitis c serine protease inhibitors
20120196829 - Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
July 2012 - Abbott Laboratories patents
20120189541 - Dual variable domain immunnoglobulins and uses thereof
20120189580 - Anti-infective agents and uses thereof
20120189709 - Method of using beta-hydroxy-beta-methylbutyrate to treat a condition
20120189717 - Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
20120189716 - Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
20120189715 - Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof
20120189714 - Compositions including beta-hydroxy-beta-methylbutyrate
20120190563 - Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
20120190681 - Picolinamide inhibitors of kinases
20120190720 - Combination therapy with parp inhibitors
20120184503 - Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
20120184559 - Novel compounds that are useful for improving pharmacokinetics
20120184991 - Suture locking device and methods
20120177704 - Crystalline anti-human il-12 antibodies
20120177744 - Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer
20120177752 - Nutritional compositions including beta-hydroxy-beta-methylbutyrate
20120178637 - Biomarkers and methods for detecting alzheimer's disease
20120178811 - Method of using beta-hydroxy-beta-methylbutyrate to reduce the risk of infection in an elderly individual
20120171165 - Human milk oligosaccharides to promote growth of beneficial bacteria
20120171166 - Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
20120171235 - Markers of xmrv infection and uses thereof
20120171350 - Nutritional products including monoglycerides and fatty acids
20120172290 - Anti-viral compounds
20120172307 - Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
20120172319 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
20120172327 - Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
20120172331 - Methods of using human milk oligosaccharides for improving airway respiratory health
20120172330 - Human milk oligosaccharides for modulating inflammation
20120172434 - Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
20120172443 - Nutritional products including a novel fat system including monoglycerides
20120172442 - Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
20120172445 - Nutritional products including a novel fat system including fatty acids
June 2012 - Abbott Laboratories patents
20120164070 - Benzothiazole and benzooxazole derivatives and methods of use
20120165861 - Snare
20120152858 - Apparatus and method for separation of whole blood into plasma or serum and cells
20120156682 - Allelic discrimination analysis using an efficiency related value (efr)
20120156805 - Assay for immunosuppressant drugs
20120157470 - Salts and crystalline forms of an apoptosis-inducing agent
20120157602 - Copolymers having zwitterionic moieties and dihdroxyphenyl moieties and medical devices coated with the copolymers
20120149726 - Crystal forms of kinase inhibitors
20120150201 - Vascular suturing device with needle capture
20120142022 - Glycosylated mammalian ngal and use thereof
May 2012 - Abbott Laboratories patents
20120134570 - High throughput, optical method and system for determining the effect of a test substance on non-contiguous living cells
20120128863 - Tensioning process for coating balloon
20120129196 - Highly sensitive monoclonal antibody residual detection assay
20120129727 - Efficient and effective supplement screening for the development of chemically defined media in cell culture
20120129853 - Methods of treatment using selective bcl-2 inhibitors
20120122076 - Purification of antibodies using simulated moving bed chromatography
20120122125 - Anti-t. cruzi antibodies and methods of use
20120122239 - Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
20120122842 - Nampt and rock inhibitors
20120122846 - Furo[3,2-d]pyrimidine compounds
20120122888 - Potassium channel modulators
20120122890 - Potassium channel modulators
20120122924 - Nampt inhibitors
20120123688 - Raman spectroscopy for bioprocess operations
20120112886 - Articles containing chipless radio frequency identification elements
20120114652 - Anti-pai-1 antibodies and methods of use thereof
20120115244 - Materials and methods for immunoassay of pterins
20120115918 - Anti-viral compounds
20120108590 - Melt-extruded solid dispersions containing an apoptosis-inducing agent
20120108637 - Fused bicyclic-substituted amines as histamine-3 receptor ligands
April 2012 - Abbott Laboratories patents
20120087858 - Dual variable domain immunoglobulins and uses thereof
March 2012 - Abbott Laboratories patents
20120075325 - Systems and methods for displaying molecular probes and chromosomes
20120076803 - Antibodies to troponin i and methods of use thereof
20120077213 - Cell culture improvements
20120071334 - Methods and marker combinations for screening for predisposition to lung cancer
20120071651 - Processes for preparing 1,2-substituted cyclopropyl derivatives
20120064141 - Drug-coated balloon with location-specific plasma treatment
20120064223 - Drug coated balloon surface relaxation process to minimize drug loss
20120065085 - Detection of chromosomal abnormalities associated with endometrial cancer
20120065219 - Spirocyclic azaadamantane derivatives and methods of use
20120065583 - Process for folding of drug coated balloon
20120065622 - Color coded guide wire and methods of making same
20120055614 - Self-expanding pseudo-braided intravascular device
20120057813 - Fluid bearing to support stent tubing during laser cutting
20120058462 - Molecular detection of xmrv infection
20120058461 - Molecular detection of xmrv infection
20120053345 - Indazole compounds
February 2012 - Abbott Laboratories patents
20120045524 - Combination therapy with parp inhibitors
20120046303 - Benzimidazole poly(adp ribose)polymerase inhibitors
20120039900 - Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
20120041003 - Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
20120034117 - Methods and systems for forming a tube for use with a pump delivery system
20120034160 - Dual variable domain immunoglobulins and uses thereof
20120028908 - Methods of manufacturing crystalline forms of rapamycin analogs
20120028925 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
January 2012 - Abbott Laboratories patents
20120020972 - Antibodies relating to pivka-ii and uses thereof
20120022089 - Solid pharmaceutical dosage form
20120022103 - Antagonists of the trpv1 receptor and uses thereof
20120022252 - Phosphine ligands for catalytic reactions
20120022253 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
20120014913 - Process for preparing antiviral compounds
20120014957 - Dual variable domain immunoglobulins and uses thereof
20120015929 - Novel compounds as cannabinoid receptor ligands
20120015963 - Novel pyrazolo[3,4-d]pyrimidine compounds
20120009196 - Monoclonal antibodies against hepatitis c virus core protein
20120000791 - Method of descaling metallic devices
20120000929 - Packaging for powdered beverage and dispenser therefor
20120000934 - Dispensing appliance for dispensing a beverage from a powdered beverage container
20120002501 - Mixing system for mixing a powdered beverage with a liquid
August 2011 - Abbott Laboratories patents
20110201060 - Process for the preparation of scyllo-inositol
20110201130 - Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
20110201967 - Catheter deplyment device
20110196010 - Crystalline chemotherapeutic
20110196387 - Vascular suturing device
20110186570 - Container
20110190314 - Pharmaceutical compositions and their methods of use
20110190489 - Novel tricyclic compounds
20110190540 - Methods for preparing s1p receptor agonists and antagonists
July 2011 - Abbott Laboratories patents
20110184509 - Dual sheath assembly and method of use
20110178096 - Octahydropentalene compounds as chemokine receptor antagonists
20110178121 - Methods for treating pain
20110171648 - Method of detecting and quantifying hepatitis c virus
20110171662 - Non-denaturing lysis reagent
20110165063 - Il-1 binding proteins
20110166171 - Sustained release monoeximic formulations of opioid and nonopioid analgesics
20110166250 - Copolymers having zwitterionic moieties and dihydroxyphenyl moieties and medical devices coated with the copolymers
June 2011 - Abbott Laboratories patents
20110159005 - 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof
20110159085 - Abt-263 capsule
20110160233 - Anti-viral compounds
20110160331 - Amino acid mimetic copolymers and medical devices coated with the copolymers
20110160382 - Copolymers having zwitterionic moieties and dihdroxyphenyl moieties and medical devices coated with the copolymers
20110160391 - Amino acid mimetic copolymers and medical devices coated with the copolymers
20110160417 - Amino acid mimetic copolymers and medical devices coated with the copolymers
20110147294 - System for processing magnetic particles
20110150704 - Container having gas scrubber insert for automated clinical analyzer
20110150861 - Sorf constructs and multiple gene expression
20110151023 - Combination therapy with parp inhibitors
20110151502 - Method for performing a blood count and determining the morphology of a blood smear
20110152243 - Novel thienopyrrole compounds
20110152248 - Bridgehead amine ring-fused indoles and indolines
20110152250 - Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof
20110152265 - Carboxamide compounds and their use as calpain inhibitors v
20110152306 - Aza-bridged ring-fused indoles and indolines
20110152308 - Aza-ring fused indole and indoline derivatives
20110152325 - Carboxamide compounds and their use as calpain inhibitors iv
20110152336 - Combination therapy with parp inhibitors
20110154521 - Transgenic animals expressing antibodies specific for genes of interest and uses thereof
20110142761 - Il-1 binding proteins
20110142845 - Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof
20110144057 - Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof
20110144165 - Prodrug compounds useful as cannabinoid ligands
20110144343 - Process for preparing cannabinoid receptor ligands
20110136103 - Autoantibody enhanced immunoassays and kits
20110136141 - Peptide reagents and method for inhibiting autoantibody antigen binding
20110136256 - Methods and kits for decreasing interferences in plasma or serum containing assay samples of specific binding assays
20110137015 - Markers of xmrv infection and uses thereof
20110137633 - Anti-viral compounds and methods of identifying the same
20110129818 - Assay for cardiac troponin-t (ctnt)
20110129854 - Assay for diagnosis of cardiac myocyte damage
20110130295 - Diagnostic methods for determining prognosis of non-small cell lung cancer
20110130382 - Modulators of 5-ht receptors and methods of use thereof
May 2011 - Abbott Laboratories patents
20110123702 - Room temperature-curable polymers
20110124012 - Assays for human nt-pro b-type natriuretic peptide, human pro b-type natriuretic peptide and human b-type natriuretic peptide
20110124628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
20110124632 - Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
20110124642 - Potassium channel modulators
20110124676 - Biaryl substituted azabicyclic alkane derivatives
20110117079 - Therapeutic dll4 binding proteins
20110117603 - Enhancement of cellular production through mechanotransduction
20110118301 - Amino-aza-adamantane derivatives and methods of use
20110112624 - Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices
20110104174 - Antibodies to receptor for advanced glycation end products (rage) and uses thereof
20110105341 - Diagnostic methods for determining prognosis of non-small cell lung cancer
20110105476 - Substituted 7,8-dihydro-1hpyrimido[4,5-b]diazepin-4-amines are novel kinase inhibitors
20110105502 - Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
20110106104 - Snared suture trimmer
20110106138 - Expandable emboli filter and thrombectomy device
April 2011 - Abbott Laboratories patents
20110098285 - Bicyclic-substituted amines as histamine-3 receptor ligands
20110091372 - Dual variable domain immunoglobulins and uses thereof
20110091423 - Compositions and methods of use of ritonavir for treating hcv
20110091463 - Dual variable domain immunoglobulins and uses thereof
20110091868 - Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
20110091997 - Immunosuppressant drug extraction reagent for immunoassays
20110092445 - Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
20110086838 - Novel compounds as cannabinoid receptor ligands
20110086832 - Novel compounds as cannabinoid receptor ligands
20110086855 - Novel compounds as cannabinoid receptor ligands and uses thereof
20110086863 - Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
20110086879 - Carboxamide compounds and their use as calpain inhibitors
20110082097 - Amino acid composition for improving glucose tolerance
20110082116 - Novel compounds as cannabinoid receptor ligands
20110082170 - Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
March 2011 - Abbott Laboratories patents
20110077670 - Articulating suturing device and method
20110070193 - Anti-infective agents and uses thereof
20110071151 - Abt-263 crystalline forms
20110071472 - Systems for anchoring a medical device in a body lumen
20110071552 - Articulating suturing device and method
20110071567 - Articulating suturing and device and method
20110062352 - Device for use in normalizing readings on a testing machine
20110065685 - Novel indoles are cannabinoid receptor ligands
20110065930 - Process for the synthesis of (2s,3ar,7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril
20110066164 - Modular clip applier
20110066184 - Articulating suturing device and method
20110059983 - Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
20110060400 - Visible endoprosthesis
20110053179 - Biomarkers for prediction of major adverse cardiac events and uses thereof
20110053206 - Method of using ligand-free lysing agent in hemoglobin analysis
20110054492 - Medical device for repairing a fistula
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbott Laboratories in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbott Laboratories with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
